Vor Biopharma Inc
General ticker "VOR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $61.6M
Vor Biopharma Inc does not follow the US Stock Market performance with the rate: -34.0%.
Estimated limits based on current volatility of 4.5%: low 0.82$, high 0.90$
Factors to consider:
- Current price 37.2% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.38$, 3.44$]
- 2024-12-30 to 2025-12-30 estimated range: [1.52$, 3.66$]
Financial Metrics affecting the VOR estimates:
- Negative: Non-GAAP EPS, $ of -1.76 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -41.15 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0
Short-term VOR quotes
Long-term VOR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $69.02MM | $93.42MM | $126.04MM |
| Operating Income | $-69.02MM | $-93.42MM | $-126.04MM |
| Non-Operating Income | $0.12MM | $1.32MM | $8.17MM |
| R&D Expense | $47.53MM | $64.55MM | $94.31MM |
| Income(Loss) | $-68.90MM | $-92.09MM | $-117.86MM |
| Profit(Loss) | $-68.90MM | $-92.09MM | $-117.86MM |
| Stockholders Equity | $216.26MM | $250.61MM | $150.72MM |
| Assets | $242.59MM | $299.37MM | $198.13MM |
| Operating Cash Flow | $-69.14MM | $-85.14MM | $-100.29MM |
| Capital expenditure | $3.89MM | $8.46MM | $1.07MM |
| Investing Cash Flow | $-91.65MM | $-94.09MM | $71.01MM |
| Financing Cash Flow | $232.91MM | $117.14MM | $2.94MM |
| Earnings Per Share* | $-1.85 | $-2.29 | $-1.75 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.